Cancer Moonshot℠ – Funding Opportunities
The funding opportunity announcements (FOAs) listed below highlight research initiatives that align with the efforts of the Cancer Moonshot. They may be supported with existing funds or with the 21st Century Cures funding.
Planning for implementation of longer-term scientific initiatives is also underway. We will continue to update this page as new funding opportunities become available so check back often or sign up to receive automatic email updates on Cancer Moonshot-related activities.
Learn about the upcoming funding opportunities presented at the joint meeting of the National Cancer Advisory Board and the Board of Scientific Advisors.
Please note that all publications and data resulting from Cancer Moonshot funded initiatives will be required to be immediately accessible. For more information, see the Cancer Moonshot Public Access and Data Sharing Policy.
| BRP Recommendation | Title | Announcement Number | Opening Date | Expiration Date |
|---|---|---|---|---|
| Cancer Immunotherapy Translational Science Network | Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) | PAR-17-244 | 1/5/2016 | 5/8/2020 |
| Cancer Immunotherapy Translational Science Network | Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) | PAR-17-245 | 1/5/2016 | 5/8/2020 |
| Cancer Immunotherapy Translational Science Network | Metabolic Reprogramming to Improve Immunotherapy (R01) | PAR-16-228 | 9/5/2016 | 9/8/2019 |
| Cancer Immunotherapy Translational Science Network | Metabolic Reprogramming to Improve Immunotherapy (R21) | PAR-16-229 | 9/16/2016 | 9/8/2019 |
| Fusion Oncoproteins in Childhood Cancers | Gene Fusions in Pediatric Sarcomas (R01) | PA-16-251 | 9/5/2016 | 5/8/2019 |
| Fusion Oncoproteins in Childhood Cancers | Gene Fusions in Pediatric Sarcomas (R21) | PA-16-252 | 9/16/2016 | 5/8/2019 |
| Fusion Oncoproteins in Childhood Cancers | Administrative Supplements to Promote Research Collaborations on Fusion Oncoproteins as Drivers of Childhood Cancer (Admin Supp) | PA-17-138 | 3/1/2017 | 3/29/2018 |
| Fusion Oncoproteins in Childhood Cancers | Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54) | RFA-CA-17-049 | 10/15/2017 | 11/16/2017 |
| Prevention and Early Detection: Implementation Science | Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21) | PAR-16-201 | 9/11/2016 | 6/14/2019 |
| Prevention and Early Detection: Implementation Science | Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01) | PAR-16-202 | 9/11/2016 | 6/14/2019 |
| Prevention and Early Detection: Implementation Science | Dissemination and Implementation Research in Health (R21) | PAR-16-236 | 5/16/2016 | 5/8/2019 |
| Prevention and Early Detection: Implementation Science | Dissemination and Implementation Research in Health (R01) | PAR-16-238 | 5/10/2016 | 5/8/2019 |
| Prevention and Early Detection: Implementation Science | Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01) | RFA-CA-17-041 | 12/9/2017 | 1/10/2018 |
| Generation of Human Tumor Atlases | Emerging Questions in Cancer Systems Biology (U01) | PAR-16-131 | 5/24/2016 | 11/24/2018 |
| New Enabling Technologies | Activities to Promote Technology Research Collaborations (APTRC) for Cancer Research (Admin Supp) | PA-17-143 | 3/12/2017 | 12/13/2017 |
| BRP Recommendation | Title | Announcement Number | Opening Date | Expiration Date |
|---|---|---|---|---|
| Cancer Immunotherapy Translational Science Network | Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy (Admin Supp) | PA-17-248 | 5/15/2017 | 6/16/2017 |
| New Enabling Technologies | Integration and Validation of Emerging Technologies to Accelerate Cancer Research (R33) | RFA-CA-17-023 | 4/10/2017 | 5/11/2017 |
| Cancer Immunotherapy Translational Science Network | Canine Immunotherapy Trials and Correlative Studies (U01) | RFA-CA-17-001 | 2/7/2017 | 3/8/2017 |
| Cancer Immunotherapy Translational Science Network | Coordinating Center for Canine Immunotherapy Trials and Correlative Studies (U24) | RFA-CA-17-002 | 2/7/2017 | 3/8/2017 |
| Cancer Immunotherapy Translational Science Network | Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies on the Tumor Microenvironment (U01) | RFA-CA-17-015 | 2/7/2017 | 3/8/2017 |
| Cancer Immunotherapy Translational Science Network | Resource Center for the Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies (U24) | RFA-CA-17-016 | 2/7/2017 | 3/8/2017 |
| Cancer Immunotherapy Translational Science Network | Cancer Immune Monitoring and Analysis Centers (CIMACs) (U24) | RFA-CA-17-005 | 2/17/2017 | 3/18/2017 |
| Cancer Immunotherapy Translational Science Network | Cancer Immunologic Data Common (CIDC) (U24) | RFA-CA-17-006 | 2/17/2017 | 3/18/2017 |
| Therapeutic Target Identification to Overcome Resistance | Mechanisms of Cancer Drug Resistance and Sensitivity (U54) | RFA-CA-17-009 | 2/3/2017 | 3/4/2017 |
| National Cancer Data Ecosystem | PDX Development and Trial Centers (PDTCs) (U54) | RFA-CA-17-003 | 2/3/2017 | 3/4/2017 |
| National Cancer Data Ecosystem | PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24) | RFA-CA-17-004 | 2/3/2017 | 3/4/2017 |